메뉴 건너뛰기




Volumn 33, Issue 2, 2004, Pages 319-334

Management of refractory inflammatory bowel disease

Author keywords

[No Author keywords available]

Indexed keywords

BALSALAZIDE; BUDESONIDE; CELECOXIB; CYCLOSPORIN; HYDROCORTISONE; INFLIXIMAB; MESALAZINE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; OLSALAZINE; PREDNISONE; ROFECOXIB; SALAZOSULFAPYRIDINE;

EID: 2942529109     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2004.02.011     Document Type: Review
Times cited : (9)

References (101)
  • 2
    • 0023521441 scopus 로고
    • Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: A randomized study
    • Schroeder K.W., Tremaine W.J., Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med. 317:1987;1625-1629
    • (1987) N Engl J Med , vol.317 , pp. 1625-1629
    • Schroeder, K.W.1    Tremaine, W.J.2    Ilstrup, D.M.3
  • 3
  • 4
    • 0033504205 scopus 로고    scopus 로고
    • Serologic testing for inflammatory bowel disease
    • Hoffenberg E.J., Fidanza S., Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr. 134:1999;447-452
    • (1999) J Pediatr , vol.134 , pp. 447-452
    • Hoffenberg, E.J.1    Fidanza, S.2    Sauaia, A.3
  • 5
    • 0036726184 scopus 로고    scopus 로고
    • Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens
    • Landers C.J., Cohavy O., Misra R., Yang H., Lin Y.C., Braun J., et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 123:2002;689-699
    • (2002) Gastroenterology , vol.123 , pp. 689-699
    • Landers, C.J.1    Cohavy, O.2    Misra, R.3    Yang, H.4    Lin, Y.C.5    Braun, J.6
  • 6
    • 0034887447 scopus 로고    scopus 로고
    • Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease
    • Sandborn W.J., Loftus E.V., Colombel J.F., Fleming K.A., Seibold F., Homburger H.A., et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 7:2001;192-201
    • (2001) Inflamm Bowel Dis , vol.7 , pp. 192-201
    • Sandborn, W.J.1    Loftus, E.V.2    Colombel, J.F.3    Fleming, K.A.4    Seibold, F.5    Homburger, H.A.6
  • 7
    • 0036242774 scopus 로고    scopus 로고
    • The value of serologic markers in indeterminate colitis: A prospective follow-up study
    • Joossens S., Reinisch W., Vermeire S., Sendid B., Poulain D., Peeters M., et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 122:2002;1242-1247
    • (2002) Gastroenterology , vol.122 , pp. 1242-1247
    • Joossens, S.1    Reinisch, W.2    Vermeire, S.3    Sendid, B.4    Poulain, D.5    Peeters, M.6
  • 8
    • 0037372740 scopus 로고    scopus 로고
    • Diagnosing small bowel Crohn's disease with wireless capsule endoscopy
    • Fireman Z., Mahajna E., Broide E., Shapiro M., Fich L., Sternberg A., et al. Diagnosing small bowel Crohn's disease with wireless capsule endoscopy. Gut. 52:2003;390-392
    • (2003) Gut , vol.52 , pp. 390-392
    • Fireman, Z.1    Mahajna, E.2    Broide, E.3    Shapiro, M.4    Fich, L.5    Sternberg, A.6
  • 9
    • 0242668401 scopus 로고    scopus 로고
    • Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium follow-through and computerized tomography in patients with suspected Crohn's disease
    • Eliakim R., Fischer D., Suissa A., Yassin K., Kathz D., Guttman N., et al. Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium follow-through and computerized tomography in patients with suspected Crohn's disease. Eur J Gastroenterol Hepatol. 15:2003;363-367
    • (2003) Eur J Gastroenterol Hepatol , vol.15 , pp. 363-367
    • Eliakim, R.1    Fischer, D.2    Suissa, A.3    Yassin, K.4    Kathz, D.5    Guttman, N.6
  • 10
    • 0002243814 scopus 로고    scopus 로고
    • Medical therapy for ulcerative colitis
    • J.B. Kirsner. Philadelphia: WB Saunders
    • Hanauer S.B. Medical therapy for ulcerative colitis. Kirsner J.B. Inflammatory bowel disease. 5th edition:2000;529-556 WB Saunders, Philadelphia
    • (2000) Inflammatory Bowel Disease 5th Edition , pp. 529-556
    • Hanauer, S.B.1
  • 13
    • 0035070678 scopus 로고    scopus 로고
    • Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naïve patient
    • Pfau P., Kochman M.L., Furth E.E., Lichtenstein G.R. Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naïve patient. Am J Gastroenterol. 96:2001;895-899
    • (2001) Am J Gastroenterol , vol.96 , pp. 895-899
    • Pfau, P.1    Kochman, M.L.2    Furth, E.E.3    Lichtenstein, G.R.4
  • 14
    • 0027949313 scopus 로고
    • Cytomegalovirus as an exacerbating factor in ulcerative colitis
    • Loftus E.V., Alexander G.L., Carpenter H.A. Cytomegalovirus as an exacerbating factor in ulcerative colitis. J Clin Gastroenterol. 19:1994;306-309
    • (1994) J Clin Gastroenterol , vol.19 , pp. 306-309
    • Loftus, E.V.1    Alexander, G.L.2    Carpenter, H.A.3
  • 15
    • 0035074282 scopus 로고    scopus 로고
    • Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis
    • Cottone M., Pietrosi G., Martorana G., Casa A., Pecoraro G., Oliva L., et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol. 96:2001;773-775
    • (2001) Am J Gastroenterol , vol.96 , pp. 773-775
    • Cottone, M.1    Pietrosi, G.2    Martorana, G.3    Casa, A.4    Pecoraro, G.5    Oliva, L.6
  • 16
    • 0033910277 scopus 로고    scopus 로고
    • Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis
    • Farrell R.J., LaMont J.T. Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis. Curr Top Microbiol Immunol. 250:2000;109-125
    • (2000) Curr Top Microbiol Immunol , vol.250 , pp. 109-125
    • Farrell, R.J.1    Lamont, J.T.2
  • 17
    • 0019484831 scopus 로고
    • Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease
    • Trnka Y.M., LaMont J.T. Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology. 80:1981;693-696
    • (1981) Gastroenterology , vol.80 , pp. 693-696
    • Trnka, Y.M.1    Lamont, J.T.2
  • 19
    • 0018882007 scopus 로고
    • Clostridium difficile associated diarrhea: A role in inflammatory bowel disease?
    • Bolton R.P., Sherriff R.J., Read A.E. Clostridium difficile associated diarrhea: a role in inflammatory bowel disease? Lancet. 1:1980;383-384
    • (1980) Lancet , vol.1 , pp. 383-384
    • Bolton, R.P.1    Sherriff, R.J.2    Read, A.E.3
  • 20
    • 0020075838 scopus 로고
    • Clostridium difficile toxin in acute diarrhea complicating inflammatory bowel disease
    • Keighley M.R.B., Youngs D., Johnson M., Allan R.N., Burdon D.W. Clostridium difficile toxin in acute diarrhea complicating inflammatory bowel disease. Gut. 23:1982;410-414
    • (1982) Gut , vol.23 , pp. 410-414
    • Keighley, M.R.B.1    Youngs, D.2    Johnson, M.3    Allan, R.N.4    Burdon, D.W.5
  • 21
    • 0020698575 scopus 로고
    • Occurrence of Clostridium difficile toxin in inflammatory bowel disease
    • Rolny P., Jarnerot G., Mollby R. Occurrence of Clostridium difficile toxin in inflammatory bowel disease. Scand J Gastroenterol. 18:1983;61-64
    • (1983) Scand J Gastroenterol , vol.18 , pp. 61-64
    • Rolny, P.1    Jarnerot, G.2    Mollby, R.3
  • 22
    • 2942580368 scopus 로고    scopus 로고
    • The diagnostic yield of stool studies during relapses of inflammatory bowel disease
    • [abstract]
    • Meyer A.M., Ramzan N.N., Loftus E.V., et al. The diagnostic yield of stool studies during relapses of inflammatory bowel disease. [abstract] Gastroenterology. 122:(4 Suppl 1):2002;A-219
    • (2002) Gastroenterology , vol.122 , Issue.4 SUPPL. 1 , pp. 219
    • Meyer, A.M.1    Ramzan, N.N.2    Loftus, E.V.3
  • 23
    • 0034827897 scopus 로고    scopus 로고
    • Failure of single-toxin assays to detect Clostridium difficile infection in pediatric inflammatory bowel disease
    • Markowitz J.E., Brown K.A., Mamula P., Drott H.R., Piccoli D.A., Baldassano R.N. Failure of single-toxin assays to detect Clostridium difficile infection in pediatric inflammatory bowel disease. Am J Gastroenterol. 96:2001;2688-2690
    • (2001) Am J Gastroenterol , vol.96 , pp. 2688-2690
    • Markowitz, J.E.1    Brown, K.A.2    Mamula, P.3    Drott, H.R.4    Piccoli, D.A.5    Baldassano, R.N.6
  • 24
    • 0031742216 scopus 로고    scopus 로고
    • Clostridium difficile-associated diarrhea and colitis: Clinical manifestations, diagnosis, and treatment
    • Cleary R.K. Clostridium difficile-associated diarrhea and colitis: clinical manifestations, diagnosis, and treatment. Dis Colon Rectum. 41:1998;1435-1449
    • (1998) Dis Colon Rectum , vol.41 , pp. 1435-1449
    • Cleary, R.K.1
  • 25
    • 0031050776 scopus 로고    scopus 로고
    • Ulcerative colitis practice guidelines in adults
    • Kornbluth A., Sachar D.B. Ulcerative colitis practice guidelines in adults. Am J Gastroenterol. 92:1997;204-211
    • (1997) Am J Gastroenterol , vol.92 , pp. 204-211
    • Kornbluth, A.1    Sachar, D.B.2
  • 26
    • 6844237647 scopus 로고    scopus 로고
    • Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis
    • Green J.R.B., Lobo A.J., Holdsworth C.D., Leicester R.J., Gibson J.A., Kerr G.D., et al. Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. Gastroenterology. 114:1998;15-22
    • (1998) Gastroenterology , vol.114 , pp. 15-22
    • Green, J.R.B.1    Lobo, A.J.2    Holdsworth, C.D.3    Leicester, R.J.4    Gibson, J.A.5    Kerr, G.D.6
  • 27
    • 0001845158 scopus 로고    scopus 로고
    • The pharmacology of anti-inflammatory drugs in inflammatory bowel disease
    • J.B. Kirsner. Philadelphia: WB Saunders
    • Hanauer S.B., Kane S. The pharmacology of anti-inflammatory drugs in inflammatory bowel disease. Kirsner J.B. Inflammatory bowel disease. 5th edition:2000;510-528 WB Saunders, Philadelphia
    • (2000) Inflammatory Bowel Disease 5th Edition , pp. 510-528
    • Hanauer, S.B.1    Kane, S.2
  • 28
    • 0034093057 scopus 로고    scopus 로고
    • Genotypic analysis of thiopurine s-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
    • Colombel J.F., Ferrari N., Debuysere H., Marteau P., Gendre J.P., Bonaz B., et al. Genotypic analysis of thiopurine s-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology. 118:2000;1025-1030
    • (2000) Gastroenterology , vol.118 , pp. 1025-1030
    • Colombel, J.F.1    Ferrari, N.2    Debuysere, H.3    Marteau, P.4    Gendre, J.P.5    Bonaz, B.6
  • 29
    • 0038054562 scopus 로고    scopus 로고
    • Ten common errors in the management of inflammatory bowel disease
    • Sachar D.B. Ten common errors in the management of inflammatory bowel disease. Inflamm Bowel Dis. 9:2003;205-209
    • (2003) Inflamm Bowel Dis , vol.9 , pp. 205-209
    • Sachar, D.B.1
  • 30
    • 0034067784 scopus 로고    scopus 로고
    • Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
    • Dubinsky M.C., Lamothe S., Yang H.Y., Targan S.R., Sinnett D., Theoret Y., et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 118:2000;705-713
    • (2000) Gastroenterology , vol.118 , pp. 705-713
    • Dubinsky, M.C.1    Lamothe, S.2    Yang, H.Y.3    Targan, S.R.4    Sinnett, D.5    Theoret, Y.6
  • 31
    • 0035037706 scopus 로고    scopus 로고
    • Utilisation of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease
    • Cuffari C., Hunt S., Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease. Gut. 48:2001;642-646
    • (2001) Gut , vol.48 , pp. 642-646
    • Cuffari, C.1    Hunt, S.2    Bayless, T.3
  • 32
    • 0035037703 scopus 로고    scopus 로고
    • Rational dosing of azathioprine and 6-mercaptopurine
    • Sandborn W.J. Rational dosing of azathioprine and 6-mercaptopurine. Gut. 48:2001;591-592
    • (2001) Gut , vol.48 , pp. 591-592
    • Sandborn, W.J.1
  • 33
    • 2942515666 scopus 로고    scopus 로고
    • Red cell mean corpuscular volume correlates with 6 thioguanine nucleotide levels during azathioprine or 6-MP therapy for Crohn's disease
    • [abstract]
    • Jobson B., Garza A., Sninsky C.A. Red cell mean corpuscular volume correlates with 6 thioguanine nucleotide levels during azathioprine or 6-MP therapy for Crohn's disease. [abstract] Gastroenterology. 120:(5 Suppl 1):2001;A4
    • (2001) Gastroenterology , vol.120 , Issue.5 SUPPL. 1 , pp. 4
    • Jobson, B.1    Garza, A.2    Sninsky, C.A.3
  • 34
    • 0029134702 scopus 로고
    • Azathioprine and 6-mercaptopurine in Crohn's disease: A meta-analysis
    • Pearson D.C., May G.R., Fick G.H., Sutherland L.H. Azathioprine and 6-mercaptopurine in Crohn's disease: a meta-analysis. Ann Intern Med. 122:1995;132-142
    • (1995) Ann Intern Med , vol.122 , pp. 132-142
    • Pearson, D.C.1    May, G.R.2    Fick, G.H.3    Sutherland, L.H.4
  • 36
    • 0000189229 scopus 로고    scopus 로고
    • Medical therapy for Crohn's disease
    • J.B. Kirsner. Philadelphia: WB Saunders
    • Lang K.A., Peppercorn M.A. Medical therapy for Crohn's disease. Kirsner J.B. Inflammatory bowel disease. 5th edition:2000;557-577 WB Saunders, Philadelphia
    • (2000) Inflammatory Bowel Disease 5th Edition , pp. 557-577
    • Lang, K.A.1    Peppercorn, M.A.2
  • 37
    • 0036897225 scopus 로고    scopus 로고
    • Infliximab in the treatment of Crohn's disease: A user's guide for clinicians
    • Sandborn W.J., Hanauer S.B. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroenterol. 97:2002;2962-2972
    • (2002) Am J Gastroenterol , vol.97 , pp. 2962-2972
    • Sandborn, W.J.1    Hanauer, S.B.2
  • 38
    • 0029044783 scopus 로고
    • Rectal aminosalicylate therapy for distal ulcerative colitis: A meta-analysis
    • Marshall J.K., Irvine E.J. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther. 9:1995;293-300
    • (1995) Aliment Pharmacol Ther , vol.9 , pp. 293-300
    • Marshall, J.K.1    Irvine, E.J.2
  • 39
    • 0032063660 scopus 로고    scopus 로고
    • Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: Results of a multicentered placebo-controlled trial
    • Hanauer S.B. Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. Inflamm Bowel Dis. 4:1998;79-83
    • (1998) Inflamm Bowel Dis , vol.4 , pp. 79-83
    • Hanauer, S.B.1
  • 40
    • 0030827118 scopus 로고    scopus 로고
    • A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis
    • Safdi M., DeMicco M., Sninsky C., Banks P., Wruble L., Deren J., et al. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol. 92:1997;1867-1871
    • (1997) Am J Gastroenterol , vol.92 , pp. 1867-1871
    • Safdi, M.1    Demicco, M.2    Sninsky, C.3    Banks, P.4    Wruble, L.5    Deren, J.6
  • 42
    • 0024517127 scopus 로고
    • Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease
    • Kozarek R.A., Patterson D.J., Gelfand M.D., Botoman V.A., Ball T.J., Wilske K.R. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med. 110:1989;353-356
    • (1989) Ann Intern Med , vol.110 , pp. 353-356
    • Kozarek, R.A.1    Patterson, D.J.2    Gelfand, M.D.3    Botoman, V.A.4    Ball, T.J.5    Wilske, K.R.6
  • 43
    • 9244264980 scopus 로고    scopus 로고
    • Methotrexate in chronic active ulcerative colitis: A double blind, randomized, Israeli multicenter trial
    • Oren R., Arber N., Odes S., Moshkowitz M., Keter D., Pomeranz I., et al. Methotrexate in chronic active ulcerative colitis: a double blind, randomized, Israeli multicenter trial. Gastroenterology. 110:1996;1416-1421
    • (1996) Gastroenterology , vol.110 , pp. 1416-1421
    • Oren, R.1    Arber, N.2    Odes, S.3    Moshkowitz, M.4    Keter, D.5    Pomeranz, I.6
  • 44
    • 0001902429 scopus 로고
    • A critical review of cyclosporine therapy in inflammatory bowel disease
    • Sandborn W.J. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis. 1:1995;48-63
    • (1995) Inflamm Bowel Dis , vol.1 , pp. 48-63
    • Sandborn, W.J.1
  • 48
    • 0038460945 scopus 로고    scopus 로고
    • Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: A randomized controlled trial
    • [abstract]
    • Probert C.S.J., Hearing S.D., Schreiber S., Kuhbacher T., Ghosh S., Arnott I.D., et al. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomized controlled trial. [abstract] Gut. 52:2003;998-1002
    • (2003) Gut , vol.52 , pp. 998-1002
    • Probert, C.S.J.1    Hearing, S.D.2    Schreiber, S.3    Kuhbacher, T.4    Ghosh, S.5    Arnott, I.D.6
  • 49
    • 0036203009 scopus 로고    scopus 로고
    • Failure to yield: Drug resistance in inflammatory bowel disease
    • Tremaine W.J. Failure to yield: drug resistance in inflammatory bowel disease. Gastroenterology. 122:2002;1165-1167
    • (2002) Gastroenterology , vol.122 , pp. 1165-1167
    • Tremaine, W.J.1
  • 50
    • 0028267896 scopus 로고
    • Frequency of glucocorticoid resistance and dependency in Crohn's disease
    • Munkholm P., Langholz E., Davidsen M., Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut. 35:1994;360-362
    • (1994) Gut , vol.35 , pp. 360-362
    • Munkholm, P.1    Langholz, E.2    Davidsen, M.3    Binder, V.4
  • 51
    • 0034903792 scopus 로고    scopus 로고
    • The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
    • Faubion W.A., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Sandborn W.J. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 121:2001;255-260
    • (2001) Gastroenterology , vol.121 , pp. 255-260
    • Faubion, W.A.1    Loftus, E.V.2    Harmsen, W.S.3    Zinsmeister, A.R.4    Sandborn, W.J.5
  • 52
    • 0036088414 scopus 로고    scopus 로고
    • Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease
    • Gelbmann C.M., Rogler G., Gross V., Gierend M., Bregenzer N., Andus T., et al. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease. Am J Gastroenterol. 97:2002;1438-1445
    • (2002) Am J Gastroenterol , vol.97 , pp. 1438-1445
    • Gelbmann, C.M.1    Rogler, G.2    Gross, V.3    Gierend, M.4    Bregenzer, N.5    Andus, T.6
  • 53
    • 0034058875 scopus 로고    scopus 로고
    • Expression of glucocorticoid receptor β in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis
    • Honda M., Orii F., Ayabe T., Imai S., Ashida T., Obara T., et al. Expression of glucocorticoid receptor β in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology. 118:2000;859-866
    • (2000) Gastroenterology , vol.118 , pp. 859-866
    • Honda, M.1    Orii, F.2    Ayabe, T.3    Imai, S.4    Ashida, T.5    Obara, T.6
  • 54
    • 0033959944 scopus 로고    scopus 로고
    • High multidrug resistance (p-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy
    • Farrell R.J., Murphy A., Long A., Donnelly S., Cherikuri A., O'Toole D., et al. High multidrug resistance (p-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology. 118:2000;279-288
    • (2000) Gastroenterology , vol.118 , pp. 279-288
    • Farrell, R.J.1    Murphy, A.2    Long, A.3    Donnelly, S.4    Cherikuri, A.5    O'Toole, D.6
  • 55
    • 0036202803 scopus 로고    scopus 로고
    • 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
    • Dubinsky M.C., Yang H., Hassard P.V., Seidman E.G., Kam L.Y., Abreu M.T., et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology. 122:2002;904-915
    • (2002) Gastroenterology , vol.122 , pp. 904-915
    • Dubinsky, M.C.1    Yang, H.2    Hassard, P.V.3    Seidman, E.G.4    Kam, L.Y.5    Abreu, M.T.6
  • 56
    • 0034780344 scopus 로고    scopus 로고
    • Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide
    • Lowry P.W., Franklin C.L., Weaver A.L., Szumlanski C.L., Mays D.C., Loftus E.V., et al. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide. Gut. 49:2001;656-664
    • (2001) Gut , vol.49 , pp. 656-664
    • Lowry, P.W.1    Franklin, C.L.2    Weaver, A.L.3    Szumlanski, C.L.4    Mays, D.C.5    Loftus, E.V.6
  • 57
    • 0037434552 scopus 로고    scopus 로고
    • Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
    • Baert F., Noman M., Vermeire S., Assche G.V., Haens G.D., Carbonez A., et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med. 348:2003;601-608
    • (2003) N Engl J Med , vol.348 , pp. 601-608
    • Baert, F.1    Noman, M.2    Vermeire, S.3    Assche, G.V.4    Haens, G.D.5    Carbonez, A.6
  • 58
    • 0037379792 scopus 로고    scopus 로고
    • Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial
    • Farrell R.J., Alsahli M., Jeen Y.T., Falchuk K.R., Peppercorn M.A., Michetti P. Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial. Gastroenterology. 124:2003;917-924
    • (2003) Gastroenterology , vol.124 , pp. 917-924
    • Farrell, R.J.1    Alsahli, M.2    Jeen, Y.T.3    Falchuk, K.R.4    Peppercorn, M.A.5    Michetti, P.6
  • 59
    • 0037379757 scopus 로고    scopus 로고
    • Preventing antibodies to infliximab in patients with Crohn's disease: Optimize not immunize
    • Sandborn W.J. Preventing antibodies to infliximab in patients with Crohn's disease: optimize not immunize. Gastroenterology. 124:2003;1140-1145
    • (2003) Gastroenterology , vol.124 , pp. 1140-1145
    • Sandborn, W.J.1
  • 60
    • 0034798909 scopus 로고    scopus 로고
    • Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis
    • Kane S., Cohen R.D., Aikens J.E., Hanauer S.B. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 96:2001;2929-2933
    • (2001) Am J Gastroenterol , vol.96 , pp. 2929-2933
    • Kane, S.1    Cohen, R.D.2    Aikens, J.E.3    Hanauer, S.B.4
  • 61
    • 0020026256 scopus 로고
    • Compliance to therapy in patients on a maintenance dose of sulfasalazine
    • van Hees P.A., van Tongeren J.H. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol. 4:1982;333-336
    • (1982) J Clin Gastroenterol , vol.4 , pp. 333-336
    • Van Hees, P.A.1    Van Tongeren, J.H.2
  • 62
    • 0037245392 scopus 로고    scopus 로고
    • Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis
    • Kane S., Huo D., Aikens J., Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 114:2003;39-43
    • (2003) Am J Med , vol.114 , pp. 39-43
    • Kane, S.1    Huo, D.2    Aikens, J.3    Hanauer, S.4
  • 63
    • 0035171258 scopus 로고    scopus 로고
    • Psychiatric predictors of noncompliance in inflammatory bowel disease: Psychiatry and compliance
    • Nigro G., Angelini G., Grosso S.B., Caula G., Sategna-Guidetti C. Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance. J Clin Gastroenterol. 32:2001;66-68
    • (2001) J Clin Gastroenterol , vol.32 , pp. 66-68
    • Nigro, G.1    Angelini, G.2    Grosso, S.B.3    Caula, G.4    Sategna-Guidetti, C.5
  • 64
    • 0036918044 scopus 로고    scopus 로고
    • Is your patient taking the medicine? a simple assay to measure compliance with 5-aminosalicylic acid-containing compounds
    • Shaw I.S., Jobson B.A., Silverman D., Ford J., Hearing S.D., Ball D., et al. Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compounds. Aliment Pharmacol Ther. 16:2002;2053-2059
    • (2002) Aliment Pharmacol Ther , vol.16 , pp. 2053-2059
    • Shaw, I.S.1    Jobson, B.A.2    Silverman, D.3    Ford, J.4    Hearing, S.D.5    Ball, D.6
  • 65
    • 0035185108 scopus 로고    scopus 로고
    • Steering azathioprine safely: Lessons from pharmacogenetics
    • Aithal G.P., Hoffmann B.J. Steering azathioprine safely: lessons from pharmacogenetics. Am J Gastroenterol. 96:2001;3202-3203
    • (2001) Am J Gastroenterol , vol.96 , pp. 3202-3203
    • Aithal, G.P.1    Hoffmann, B.J.2
  • 66
    • 0036211306 scopus 로고    scopus 로고
    • Mesalamine intolerance mimics symptoms of active inflammatory bowel disease
    • Iofel E., Chawla A., Daum F., Markowitz J. Mesalamine intolerance mimics symptoms of active inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 34:2002;73-76
    • (2002) J Pediatr Gastroenterol Nutr , vol.34 , pp. 73-76
    • Iofel, E.1    Chawla, A.2    Daum, F.3    Markowitz, J.4
  • 67
    • 0033922379 scopus 로고    scopus 로고
    • Diarrhea as a side effect of mesalamine treatment for inflammatory bowel disease
    • Goldstein F., DiMarino A.J. Diarrhea as a side effect of mesalamine treatment for inflammatory bowel disease. J Clin Gastroenterol. 31:2000;60-62
    • (2000) J Clin Gastroenterol , vol.31 , pp. 60-62
    • Goldstein, F.1    Dimarino, A.J.2
  • 68
    • 0023626064 scopus 로고
    • Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides
    • Turunen U., Elomaa I., Anttila V.J., Seppala K. Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides. Scand J Gastroenterol. 22:1987;798-802
    • (1987) Scand J Gastroenterol , vol.22 , pp. 798-802
    • Turunen, U.1    Elomaa, I.2    Anttila, V.J.3    Seppala, K.4
  • 69
    • 0028823951 scopus 로고
    • Mesalazine induced exacerbation of ulcerative colitis
    • Kapur K.C., Williams G.T., Allison M.C. Mesalazine induced exacerbation of ulcerative colitis. Gut. 37:1995;838-839
    • (1995) Gut , vol.37 , pp. 838-839
    • Kapur, K.C.1    Williams, G.T.2    Allison, M.C.3
  • 71
    • 0021252279 scopus 로고
    • Acute ulcerative colitis-a rare complication of sulfasalazine therapy
    • Ruppin H., Domschke S. Acute ulcerative colitis-a rare complication of sulfasalazine therapy. Hepatogastroenterology. 31:1984;192-193
    • (1984) Hepatogastroenterology , vol.31 , pp. 192-193
    • Ruppin, H.1    Domschke, S.2
  • 72
    • 0023238082 scopus 로고
    • Salicylate induced exacerbation of ulcerative colitis
    • Chakraborty T.K., Bhatia D., Heading R.C., Ford M.J. Salicylate induced exacerbation of ulcerative colitis. Gut. 28:1987;613-615
    • (1987) Gut , vol.28 , pp. 613-615
    • Chakraborty, T.K.1    Bhatia, D.2    Heading, R.C.3    Ford, M.J.4
  • 74
    • 0029046109 scopus 로고
    • Exacerbation of chronic ulcerative colitis with mesalamine
    • Sturgeon J.B., Bhatia P., Hermens D., Miner P.B. Exacerbation of chronic ulcerative colitis with mesalamine. Gastroenterology. 108:1995;1889-1893
    • (1995) Gastroenterology , vol.108 , pp. 1889-1893
    • Sturgeon, J.B.1    Bhatia, P.2    Hermens, D.3    Miner, P.B.4
  • 75
    • 0022649415 scopus 로고
    • Azodisal sodium in the treatment of ulcerative colitis: A study of tolerance and relapse-prevention properties
    • Sandberg-Gertzen J., Jarnerot G., Kraaz W. Azodisal sodium in the treatment of ulcerative colitis: a study of tolerance and relapse-prevention properties. Gastroenterology. 90:1986;1024-1030
    • (1986) Gastroenterology , vol.90 , pp. 1024-1030
    • Sandberg-Gertzen, J.1    Jarnerot, G.2    Kraaz, W.3
  • 76
    • 0025981890 scopus 로고
    • Effects of olsalazine and sulphasalazine on jejunal and ileal water and electrolyte absorption in normal human subjects
    • Raimundo A.H., Patil D.H., Frost P.G., Silk D.B.A. Effects of olsalazine and sulphasalazine on jejunal and ileal water and electrolyte absorption in normal human subjects. Gut. 32:1991;270-274
    • (1991) Gut , vol.32 , pp. 270-274
    • Raimundo, A.H.1    Patil, D.H.2    Frost, P.G.3    Silk, D.B.A.4
  • 77
    • 18144432814 scopus 로고    scopus 로고
    • Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon
    • Puspok A., Kiener H.P., Oberhuber G. Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum. 43:2000;685-691
    • (2000) Dis Colon Rectum , vol.43 , pp. 685-691
    • Puspok, A.1    Kiener, H.P.2    Oberhuber, G.3
  • 78
    • 0031468175 scopus 로고    scopus 로고
    • Acute colitis associated with etodolac
    • Wilcox G., Porensky R.S. Acute colitis associated with etodolac. J Clin Gastroenterol. 25:1997;367-368
    • (1997) J Clin Gastroenterol , vol.25 , pp. 367-368
    • Wilcox, G.1    Porensky, R.S.2
  • 79
    • 0019476153 scopus 로고
    • Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs
    • Rampton D.S., Sladen G.E. Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs. Postgrad Med J. 57:1981;297-299
    • (1981) Postgrad Med J , vol.57 , pp. 297-299
    • Rampton, D.S.1    Sladen, G.E.2
  • 80
    • 0020680648 scopus 로고
    • Analgesic ingestion and other factors preceding relapse in ulcerative coltish
    • Rampton D.S., McNeil N.I., Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative coltish. Gut. 24:1983;187-189
    • (1983) Gut , vol.24 , pp. 187-189
    • Rampton, D.S.1    McNeil, N.I.2    Sarner, M.3
  • 81
    • 0023266579 scopus 로고
    • Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease
    • Kaufmann H.J., Taubin H.L. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med. 107:1987;513-516
    • (1987) Ann Intern Med , vol.107 , pp. 513-516
    • Kaufmann, H.J.1    Taubin, H.L.2
  • 82
    • 0030913612 scopus 로고    scopus 로고
    • Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease
    • Evans J.M.M., McMahon A.D., Murray F.E., McDevitt D.G., MacDonald T.M. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut. 40:1997;619-622
    • (1997) Gut , vol.40 , pp. 619-622
    • Evans, J.M.M.1    McMahon, A.D.2    Murray, F.E.3    McDevitt, D.G.4    MacDonald, T.M.5
  • 83
  • 84
    • 0030806609 scopus 로고    scopus 로고
    • Factors influencing the relapse of patients with inflammatory bowel disease
    • Miner P.B. Factors influencing the relapse of patients with inflammatory bowel disease. Am J Gastroenterol. 92:1997;1-4
    • (1997) Am J Gastroenterol , vol.92 , pp. 1-4
    • Miner, P.B.1
  • 85
    • 0033899563 scopus 로고    scopus 로고
    • Tolerance of nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease
    • Bonner G.F., Walczak M., Kitchen L., Bayona M. Tolerance of nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease. Am J Gastroenterol. 95:2000;1946-1948
    • (2000) Am J Gastroenterol , vol.95 , pp. 1946-1948
    • Bonner, G.F.1    Walczak, M.2    Kitchen, L.3    Bayona, M.4
  • 86
    • 0036123619 scopus 로고    scopus 로고
    • Safety of selective cyclooygenase-2 inhibitors in inflammatory bowel disease
    • Mahadevan U., Loftus E.V., Tremaine W.J., Sandborn W.J. Safety of selective cyclooygenase-2 inhibitors in inflammatory bowel disease. Am J Gastroenterol. 97:2002;910-914
    • (2002) Am J Gastroenterol , vol.97 , pp. 910-914
    • Mahadevan, U.1    Loftus, E.V.2    Tremaine, W.J.3    Sandborn, W.J.4
  • 87
    • 0033135502 scopus 로고    scopus 로고
    • Nicotine therapy for ulcerative colitis: A review of rationale, mechanisms, pharmacology, and clinical results
    • Sandborn W.J. Nicotine therapy for ulcerative colitis: a review of rationale, mechanisms, pharmacology, and clinical results. Am J Gastroenterol. 94:1999;1161-1171
    • (1999) Am J Gastroenterol , vol.94 , pp. 1161-1171
    • Sandborn, W.J.1
  • 88
    • 0029817724 scopus 로고    scopus 로고
    • Smoking and inflammatory bowel disease
    • Forbes A. Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol. 8:1996;761-763
    • (1996) Eur J Gastroenterol Hepatol , vol.8 , pp. 761-763
    • Forbes, A.1
  • 89
    • 0026563474 scopus 로고
    • Smoking in Crohn's disease: Effect on localisation and clinical course
    • Lindberg E., Jarnerot G., Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut. 33:1992;779-782
    • (1992) Gut , vol.33 , pp. 779-782
    • Lindberg, E.1    Jarnerot, G.2    Huitfeldt, B.3
  • 90
    • 0025323229 scopus 로고
    • Effect of cigarette smoking on recurrence of Crohn's disease
    • Sutherland L.R., Ramcharan S., Bryant H., et al. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology. 98:1990;1123-1128
    • (1990) Gastroenterology , vol.98 , pp. 1123-1128
    • Sutherland, L.R.1    Ramcharan, S.2    Bryant, H.3
  • 92
    • 0035087887 scopus 로고    scopus 로고
    • Smoking cessation and the course of Crohn's disease: An intervention study
    • Cosnes J., Beaugerie L., Carbonnel F., Gendre J.P. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology. 120:2001;1093-1099
    • (2001) Gastroenterology , vol.120 , pp. 1093-1099
    • Cosnes, J.1    Beaugerie, L.2    Carbonnel, F.3    Gendre, J.P.4
  • 100
    • 15644374610 scopus 로고    scopus 로고
    • Transdermal nicotine for mildly to moderately active ulcerative colitis: A randomized, double-blind, placebo-controlled trial
    • Sandborn W.J., Tremaine W.J., Offord K.P., Lawson G.M., Petersen B.T., Batts K.P., et al. Transdermal nicotine for mildly to moderately active ulcerative colitis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 126:1997;364-371
    • (1997) Ann Intern Med , vol.126 , pp. 364-371
    • Sandborn, W.J.1    Tremaine, W.J.2    Offord, K.P.3    Lawson, G.M.4    Petersen, B.T.5    Batts, K.P.6
  • 101
    • 0032865549 scopus 로고    scopus 로고
    • Nicotine treatment for ulcerative colitis
    • Guslandi M. Nicotine treatment for ulcerative colitis. Br J Clin Pharmacol. 48:1999;481-484
    • (1999) Br J Clin Pharmacol , vol.48 , pp. 481-484
    • Guslandi, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.